Ondine Biomedical (UK) Buy Hold or Sell Recommendation
| OBI Stock | 9.75 0.35 3.47% |
Assuming the 90 days trading horizon and your above-average risk tolerance, our recommendation regarding Ondine Biomedical is 'Cautious Hold'. Macroaxis provides Ondine Biomedical buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding OBI positions.
Check out Ondine Biomedical Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as Ondine and provide practical buy, sell, or hold advice based on investors' constraints. Ondine Biomedical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
Ondine |
Execute Ondine Biomedical Buy or Sell Advice
The Ondine recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Ondine Biomedical. Macroaxis does not own or have any residual interests in Ondine Biomedical or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Ondine Biomedical's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Cautious Hold
Market Performance | OK | Details | |
Volatility | Slightly risky | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | High | Details | |
Economic Sensitivity | Almost mirrors the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Ondine Biomedical Trading Alerts and Improvement Suggestions
| Ondine Biomedical had very high historical volatility over the last 90 days | |
| Ondine Biomedical has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 1.2 M. Net Loss for the year was (14.41 M) with profit before overhead, payroll, taxes, and interest of 981 K. | |
| Ondine Biomedical generates negative cash flow from operations | |
| About 43.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from news.google.com: Ondine Biomedical Expands Share Capital with New Option Exercise - TipRanks |
Ondine Biomedical Returns Distribution Density
The distribution of Ondine Biomedical's historical returns is an attempt to chart the uncertainty of Ondine Biomedical's future price movements. The chart of the probability distribution of Ondine Biomedical daily returns describes the distribution of returns around its average expected value. We use Ondine Biomedical price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Ondine Biomedical returns is essential to provide solid investment advice for Ondine Biomedical.
| Mean Return | 0.44 | Value At Risk | -6.25 | Potential Upside | 6.40 | Standard Deviation | 4.35 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Ondine Biomedical historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Ondine Biomedical Cash Flow Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change In Cash | 320K | 29.2M | (16.6M) | (10.1M) | (9.1M) | (8.7M) | |
| Free Cash Flow | (6.4M) | (12.6M) | (16.7M) | (13.8M) | (12.4M) | (11.8M) | |
| Capital Expenditures | 99K | 77K | 311K | 177K | 203.6K | 216.4K | |
| Net Income | (16.3M) | (50.1M) | (19.4M) | (14.4M) | (13.0M) | (13.6M) | |
| End Period Cash Flow | 626K | 29.9M | 13.3M | 3.1M | 3.6M | 4.5M | |
| Other Non Cash Items | 832K | 1.4M | 987K | (170K) | (153K) | (145.4K) | |
| Change To Inventory | 86K | (673K) | (337K) | 104K | 93.6K | 98.3K | |
| Depreciation | 1.2M | 514K | 493K | 587K | 675.1K | 571.0K | |
| Investments | 2.9M | (77K) | (311K) | (177K) | (159.3K) | (151.3K) |
Ondine Biomedical Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Ondine Biomedical or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Ondine Biomedical's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Ondine stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.56 | |
β | Beta against Dow Jones | 1.19 | |
σ | Overall volatility | 4.48 | |
Ir | Information ratio | 0.12 |
Ondine Biomedical Volatility Alert
Ondine Biomedical shows above-average downside volatility for the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Ondine Biomedical's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Ondine Biomedical's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Ondine Biomedical Fundamentals Vs Peers
Comparing Ondine Biomedical's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Ondine Biomedical's direct or indirect competition across all of the common fundamentals between Ondine Biomedical and the related equities. This way, we can detect undervalued stocks with similar characteristics as Ondine Biomedical or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Ondine Biomedical's fundamental indicators could also be used in its relative valuation, which is a method of valuing Ondine Biomedical by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Ondine Biomedical to competition |
| Fundamentals | Ondine Biomedical | Peer Average |
| Return On Equity | -6.86 | -0.31 |
| Return On Asset | -1.6 | -0.14 |
| Operating Margin | (9.12) % | (5.51) % |
| Current Valuation | 42.63 M | 16.62 B |
| Shares Outstanding | 442.04 M | 571.82 M |
| Shares Owned By Insiders | 42.86 % | 10.09 % |
| Shares Owned By Institutions | 21.61 % | 39.21 % |
| Price To Book | 4,240 X | 9.51 X |
| Price To Sales | 27.32 X | 11.42 X |
| Revenue | 1.2 M | 9.43 B |
| Gross Profit | 981 K | 27.38 B |
| EBITDA | (13.79 M) | 3.9 B |
| Net Income | (14.41 M) | 570.98 M |
| Total Debt | 541 K | 5.32 B |
| Cash Flow From Operations | (13.65 M) | 971.22 M |
| Earnings Per Share | (0.03) X | 3.12 X |
| Target Price | 60.0 | |
| Beta | 0.14 | -0.15 |
| Market Capitalization | 44.65 M | 19.03 B |
| Total Asset | 5.73 M | 29.47 B |
| Retained Earnings | (266.33 M) | 9.33 B |
| Working Capital | 1.26 M | 1.48 B |
| Net Asset | 5.73 M |
Ondine Biomedical Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Ondine . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Ondine Biomedical Buy or Sell Advice
When is the right time to buy or sell Ondine Biomedical? Buying financial instruments such as Ondine Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Ondine Biomedical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Agency Mbs ETFs Thematic Idea Now
Agency Mbs ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Agency Mbs ETFs theme has 11 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Agency Mbs ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Ondine Stock
Ondine Biomedical financial ratios help investors to determine whether Ondine Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Ondine with respect to the benefits of owning Ondine Biomedical security.